{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "guanfacine" in Related Substance Name (exact match)
Showing 1 - 5 of 5 results
Status:
US Approved Rx
(2023)
Source:
ANDA217269
(2023)
Source URL:
First approved in 1986
Source:
TENEX by PROMIUS PHARMA
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
Status:
US Approved Rx
(2013)
First approved in 1958
Class:
MIXTURE
Status:
US Approved Rx
(2023)
Source:
ANDA217269
(2023)
Source URL:
First approved in 1986
Source:
TENEX by PROMIUS PHARMA
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
Status:
US Approved Rx
(2023)
Source:
ANDA217269
(2023)
Source URL:
First approved in 1986
Source:
TENEX by PROMIUS PHARMA
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
